The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety and feasibility of cabozantinib (CABO) in combination with cisplatin, doxorubicin, and high-dose methotrexate (MAP) in patients with newly diagnosed high-risk osteosarcoma (OS).
 
Michael Bishop
Consulting or Advisory Role - Recordati
 
Natalie DelRocco
Stock and Other Ownership Interests - CVS (I); GE Healthcare (I); Johnson & Johnson (I)
 
Allen Buxton
No Relationships to Disclose
 
Odion Binitie
No Relationships to Disclose
 
Olga Militano
No Relationships to Disclose
 
Andrew Clark
No Relationships to Disclose
 
Richard Riedel
Employment - Limbguard (I)
Leadership - Limbguard (I)
Stock and Other Ownership Interests - Limbguard (I)
Consulting or Advisory Role - AADi; Adaptimmune; Boehringer Ingelheim; Daiichi Sankyo; Deciphera; EMD Serono/Merck; GlaxoSmithKline; Recordati; SpringWorks Therapeutics
Research Funding - AADi (Inst); Arog (Inst); Ayala Pharmaceuticals (Inst); BioAtla (Inst); Blueprint Medicines (Inst); Cogent Biosciences (Inst); Daiichi Sankyo (Inst); Deciphera (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); InhibRx (Inst); Intensity Therapeutics (Inst); PTC Therapeutics (Inst); Servier (Inst); SpringWorks Therapeutics (Inst); SynOX (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - PandoNet - Limbguard (I)
Travel, Accommodations, Expenses - Daiichi Sankyo; Deciphera; NanoCarrier; Recordati; SpringWorks Therapeutics
 
Elizabeth Davis
Honoraria - MJH Life Sciences
Consulting or Advisory Role - Aadi; Deciphera
Speakers' Bureau - Physicans' Education Resource
Research Funding - Actuate Therapeutics (Inst); Cogent Biosciences (Inst); Cornerstone Pharmaceuticals (Inst); InhibRx (Inst); Karyopharm Therapeutics (Inst); Pheast Therapeutics (Inst); SERVIER (Inst); TopAlliance BioSciences Inc (Inst)
Travel, Accommodations, Expenses - Spring Works
 
J. Livingston
Consulting or Advisory Role - Ipsen
Research Funding - Exelixis (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Ipsen
Other Relationship - Guidepoint Global
 
Manpreet Bedi
No Relationships to Disclose
 
Hesham Elhalawani
No Relationships to Disclose
 
Chi Lin
Research Funding - BioMimetix
 
Nadia Laack
Employment - Mayo Clinic
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Google Health
 
Timothy Lautz
Consulting or Advisory Role - Stryker
Research Funding - Astellas Pharma; On Target Laboratories
 
Thomas Scharschmidt
Consulting or Advisory Role - Daiichi Sankyo/Lilly; Deciphera; Onkos Surgical; Stryker
Travel, Accommodations, Expenses - Onkos Surgical; Stryker
 
Megan Anderson
No Relationships to Disclose
 
Alyaa Al-Ibraheemi
No Relationships to Disclose
 
Damon Reed
Consulting or Advisory Role - Eisai; Recordati; SpringWorks Therapeutics
 
Julia Glade Bender
Consulting or Advisory Role - Renaissance Pharma; SpringWorks Therapeutics
Research Funding - Bayer (Inst); Cellectar (Inst); Eisai (Inst); Jazz Pharmaceuticals (Inst); Jazz Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent on a T lympboblastic lymphoma cell line, CUTLL1
Travel, Accommodations, Expenses - Amgen (Inst); Bayer (Inst); Eisai (Inst)
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; Eisai; Merck; Pfizer; SpringWorks Therapeutics
 
Katherine Janeway
Consulting or Advisory Role - Recordati
Research Funding - AstraZeneca (Inst); Eisai (Inst)